SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-13-002298
Filing Date
2013-12-18
Accepted
2013-12-18 13:30:48
Documents
5
Period of Report
2013-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e611670_8k-retrophin.htm 8-K 41774
2 e611670_ex10-1.htm EX-10.1 281158
3 e611670_ex10-2.htm EX-10.2 108308
4 e611670_ex10-3.htm EX-10.3 57046
5 e611670_ex10-4.htm EX-10.4 74088
  Complete submission text file 0001193805-13-002298.txt   563730
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 8-K | Act: 34 | File No.: 000-53293 | Film No.: 131284703
SIC: 2834 Pharmaceutical Preparations